169 related articles for article (PubMed ID: 37736172)
1. Novel Haloacethydrazides as AEP Inhibitors for Treating Alzheimer's Disease.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2023 Sep; 14(9):1165-1166. PubMed ID: 37736172
[TBL] [Abstract][Full Text] [Related]
2. 3-Alkynyl Carboxamides as AEP Modulators for Treating Alzheimer's Disease.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2024 Feb; 15(2):159-160. PubMed ID: 38352845
[TBL] [Abstract][Full Text] [Related]
3. Pyridazine Derivatives as NLRP3 Inhibitors for Treating Asthma, COPD, Parkinson's Disease, and Alzheimer's Disease.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1047-1048. PubMed ID: 37583813
[TBL] [Abstract][Full Text] [Related]
4. Novel Isoxazolidines as RIPK1 Inhibitors for Treating Alzheimer's Disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):447-448. PubMed ID: 38628797
[TBL] [Abstract][Full Text] [Related]
5. Novel Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2024 Jun; 15(6):750-751. PubMed ID: 38894913
[TBL] [Abstract][Full Text] [Related]
6. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
[TBL] [Abstract][Full Text] [Related]
7. Carboxylic Acid-Containing Indanyl Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2023 Aug; 14(8):1033-1034. PubMed ID: 37583826
[TBL] [Abstract][Full Text] [Related]
8. [Brain evoked potentials in patients with Alzheimer's disease and schizophrenia: a comparative study].
Chen X; Zhang M; Wang J
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):674-6. PubMed ID: 11038791
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer's Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells.
Cheng Q; Ma X; Liu J; Feng X; Liu Y; Wang Y; Ni W; Song M
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175445
[TBL] [Abstract][Full Text] [Related]
10. Novel Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
[TBL] [Abstract][Full Text] [Related]
11. Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1045-1046. PubMed ID: 37583830
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.
Wang J; Hu HJ; Liu ZK; Liu JJ; Wang SS; Cheng Q; Chen HZ; Song M
Transl Neurodegener; 2021 Mar; 10(1):12. PubMed ID: 33789744
[TBL] [Abstract][Full Text] [Related]
13. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1336-1337. PubMed ID: 37849559
[TBL] [Abstract][Full Text] [Related]
14. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
[TBL] [Abstract][Full Text] [Related]
15. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
[TBL] [Abstract][Full Text] [Related]
16. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
[TBL] [Abstract][Full Text] [Related]
17. Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):775-776. PubMed ID: 38894910
[TBL] [Abstract][Full Text] [Related]
18. Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):748-749. PubMed ID: 38894901
[TBL] [Abstract][Full Text] [Related]
19. Novel C-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2023 Jun; 14(6):698-699. PubMed ID: 37312864
[TBL] [Abstract][Full Text] [Related]
20. Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.
Zhang Z; Xie M; Ye K
Expert Opin Ther Targets; 2016 Oct; 20(10):1237-45. PubMed ID: 27115710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
